Residing at the interface of chemistry and biotechnology, artificial metalloenzymes 10 offer an attractive technology to combine the versatile reaction repertoire of transition 11 metal catalysts with the exquisite catalytic features of enzymes. While earlier efforts in 12 this field predominantly comprised studies in well-defined test-tube environments, a 13 trend towards exploitation of artificial metalloenzymes in more complex environments 14 has recently emerged. This includes the integration of these artificial biocatalysts in 15 enzymatic cascades and reaches out to their utilization in whole cell biotransformations 16 and in vivo, opening up entirely novel prospects for both preparative chemistry and 17 synthetic biology. Here we highlight selected recent developments with a particular 18 focus on challenges and opportunities for the in vivo application of artificial 19 metalloenzymes. 20 21 <Trends Box> 22 Artificial metalloenzymes (ArMs) are an emerging form of non-natural biocatalysts, 23 which allow to create biocatalytic novelty with potential applications in preparative 24 chemistry and synthetic biology.
In these cases, rational protein design can offer valuable means to introduce entirely 143 new reactivity into proteins, either by de novo design of synthetic (bottom-up) or based 144 on existing protein folds (top-down). The group of Pecoraro, for instance, has designed 145 a synthetic three-stranded coiled coil protein with a catalytically competent Zn(II) and 146 a stabilizing Hg(II) center [40, 41] . This protein exhibited hydrolytic activity for p-147 nitrophenyl acetate and CO2 hydration, the latter of which was later highly improved in mononuclear zinc deaminase, emphasizing the synergistic potential of these two 155 methods [43] . 156 A widely adopted and arguably pragmatic approach is the introduction of non-canonical 157 catalytic metal(-complexes) (i.e. artificial cofactors) into proteins using appropriate 158 anchoring strategies (vide infra). Synthetic heme derivatives have been used in which 159 either iron is replaced by metals including Mn, Co and Ir [11, 31, [44] [45] [46] or the structure variants, thereby significantly increasing the throughput. The resulting metathases 189 exhibited significantly improved activities for the screening substrate, albeit at low 190 TONs, and for other di-olefin compounds.
191
Hence, the presented ensemble of recent developments in the ArM field (Table 1) , 192 while not comprehensive and likely subjective, emphasizes their potential for the 193 creation of catalytic novelty in bio-and transition metal catalysis. Another important aspect is cellular uptake of cofactors as a limitation for ArM usage 254 in vivo in contrast to in vitro scenarios where the scaffold protein is freely accessible.
255
In particular artificial cofactors with complex ligands frequently exceed the molecular 256 weight exclusion cut-off of outer membrane porins (~600 Da) [57] and do not have 257 access to a specific cellular uptake machinery like natural cofactors such as heme [58] .
258
During our aforementioned study on artificial metathases, we identified the uptake of throughput screening assays without the need for extensive processing procedures medical applications, which was not outlined herein but elaborated on elsewhere (e.g.
432
[24, 25, 80] ).
433
In quintessence, the assimilation of ArMs by living cells is a highly auspicious, yet 434 challenging, endeavor and may contribute to a future "fourth wave" of biocatalysis 435 following Bornscheuer's metaphor [1] . What are the most pressing chemical challenges that ArMs could solve?
439
Will ArMs be able to make it "out of the niche" by outcompeting small molecule 440 catalysts in large scales and for wide applications in the near future and can they 441 contribute to the transition towards a sustainable, bio-based economy?
442
Can we combine multiple ArMs and natural enzymes with each other to engineer entire 443 artificial pathways in living organisms, which lead to the production of previously 444 inaccessible bio-products and what will the latter look like?
445
Is it possible to systematically install functional ArMs in living organisms that are 446 propagating in the presence of the ArM reaction or even benefit from it and what is the 447 potential of bringing non-natural metals (e.g. iridium, ruthenium, rhodium, palladium, 448 gold, osmium etc.) into synthetic biology?
449
Will we be able to establish biosynthesis of non-canonical cofactors to render their 450 addition to the cells obsolete?
451
What is the potential of in vivo utilization of ArMs beyond bio-production and 452 preparative chemistry? <\Outstanding Questions Box>
